• 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94: 153156.
  • 2
    Ballon SC, Berman ML, Lagasse LD, Petrilli ES, Castaldo TW. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol. 1981; 57: 9095.
  • 3
    Avrette HE, Dudan RC, Ford JH Jr. Exploratory celiotomy for surgical staging of cervical cancer. Am J Obstet Gynecol. 1972; 113: 10901096.
  • 4
    Takeshima N, Yanoh K, Tabata T, Nagai K, Hirai Y, Hasumi K. Assessment of the revised International Federation of Gynecology and Obstetrics staging for early invasive squamous cervical cancer. Gynecol Oncol. 1999; 74: 165169.
  • 5
    Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol. 1984; 23: 455459.
  • 6
    Downey GO, Potish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol. 1989; 160: 10551061.
  • 7
    Potish RA, Twigg LB, Okagaki T, Prem KA, Addcock LL. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging. Cancer. 1985; 56: 956960.
  • 8
    Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic and Oncology Group. Gynecol Oncol. 1980; 9: 9098.
  • 9
    Kupets R, Covens A. Is the International Federation of Gynecology and Obstetrics staging system for cervical carcinoma able to predict survival in patients with cervical carcinoma? An assessment of clinimetric properties. Cancer. 2001; 92: 796804.
  • 10
    Chung CK, Nahhas WA, Zaino R, Stryker JA, Mortel R. Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol. 1981; 12: 348354.
  • 11
    Van Nagell JR Jr., Roddick JW Jr., Lowin DM. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathological findings. Am J Obstet Gynecol. 1971; 110: 973978.
  • 12
    Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA. 1997; 278: 10911101.
  • 13
    Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before staging: a surgicopathologic study. J Clin Oncol. 1999; 17: 4145.
  • 14
    Reinhardt MJ, Ehritt-Braun CD, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology. 2001; 218: 776782.
  • 15
    Sugawara Y, Eisbruch A, Kosud S, Recker BE, Kison PV, Wahl RK. Evaluation of FDG-PET in patients with cervical cancer. J Nucl Med. 1999; 40: 11251131.
  • 16
    Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer. 2001; 11: 263271.
  • 17
    Park SY, Roh JW, Park YJ, et al. Positron emission tomography (PET) for evaluating para-aortic and pelvic lymph node metastasis in cervical cancer before surgical staging: a surgicopathologic study [abstract]. Proc Am Soc Clin Oncol. 2003; 22: 456a.
  • 18
    Grigsby PW, Dehadshiti F, Siegel BA. FDG-PET evaluation of carcinoma of the cervix. Clin Positron Imaging. 1999; 2: 105109.
  • 19
    Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000; 41: 13691379.
  • 20
    Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004; 231: 6572.
  • 21
    Martinelli M, Townsend D, Meltzer C, Villemagne VV. 7. Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility. Clin Positron Imaging. 2000; 3: 161164.
  • 22
    Cerfolio RJ, Ojha B, Bryant AS, et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004; 78: 10171023.
  • 23
    von Schulthess GK. Clinical molecular anatomical imaging. Philadelphia: J.B. Lippincott Company, 2003.
  • 24
    Kim S, Chung JK, Kim BT, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging. 1999; 2: 273279.
  • 25
    Ma SY, See LC, Lai CH, et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med. 2003; 44: 17751783.
  • 26
    Lanciano RM, Corn BW. The role of surgical staging for cervical cancer. Semin Radiat Oncol. 1994; 4: 4651.
  • 27
    Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992; 69: 181186.
  • 28
    Outwater E, Kressel HY. Evaluation of gynecologic malignancy by magnetic resonance imaging. Radiol Clin North Am. 1992; 30: 789806.
  • 29
    Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology. 1994; 190: 807811.
  • 30
    Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr. 2004; 28: 620627.
  • 31
    Yu KK, Hricak H, Subak LL, Zaloudek CJ, Powell CB. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR Am J Roentgenol. 1998; 171: 707711.
  • 32
    Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol. 2000; 175: 759766.
  • 33
    Wiener JI, Chako AC, Merten CW, Gross S, Coffey EL, Stein HL. Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology. 1986; 160: 299305.
  • 34
    Weissleder R, Elzondo G, Joshphson L, et al. Experimental lymph node metastases: enhanced detection with MR lymphangiography. Radiology. 1989; 171: 835839.
  • 35
    Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph nodes:microstructural anatomy of MR imaging. Radiology. 1991; 178: 519522.
  • 36
    Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph node nodes with MR imaging. Radiology. 1990; 175: 494498.
  • 37
    Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MR imaging in 99 patients. J Comput Assist Tomogr. 1993; 17: 633640.
  • 38
    Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr. 2004; 28: 620627.